Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel noncanonical Src-mammalian STE20-like kinase 1 (MST1)-Akt/glycogen synthase kinase-3β (GSK3β) pathway drives platelet activation and thrombosis.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Erratum to "Porphyromonas gingivalis lipids enhance RANKL-mediated osteoclast formation" [Bone 207 (2026) 117852].

Bone·2026
Same author

Synthesis of azido-modified enamides <i>via</i> CC isomerisation of functionalised Ugi adducts.

Organic & biomolecular chemistry·2026
Same author

Inhibition of Dot1L Histone Methyltransferase Expands Bone Injury-Responsive CXCL12<sup>+</sup> Stromal Progenitors.

bioRxiv : the preprint server for biology·2026
Same author

Porphyromonas gingivalis lipids enhance RANKL-mediated osteoclast formation.

Bone·2026
Same author

Trends in Industry-Sponsored Research Funding to Orthopaedic Surgeons in the U.S. from 2017-2024.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: May 19, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Cbl proteins in platelet activation.

Lorena Buitrago1, Alexander Tsygankov, Archana Sanjay

  • 1Department of Physiology, Temple University , Philadelphia, PA 19140 , USA.

Platelets
|August 31, 2012
PubMed
Summary
This summary is machine-generated.

Cbl proteins, including c-Cbl and Cbl-b, are crucial ubiquitin ligases regulating platelet function in hemostasis and hematological malignancies. Understanding their signaling pathways is key to controlling bleeding disorders and thrombosis.

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Related Experiment Videos

Last Updated: May 19, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Signaling

Background:

  • Platelets are essential for hemostasis, and their dysregulation can cause bleeding or thrombosis.
  • Signaling pathways controlling platelet function require tight regulation.
  • Cbl proteins (c-Cbl and Cbl-b) are emerging as key regulators in platelet biology.

Purpose of the Study:

  • To review the critical role of Cbl proteins in regulating platelet functional responses.
  • To elucidate the dual regulatory functions (positive and negative) of Cbl proteins in platelet signaling.
  • To highlight the significance of Cbl proteins in both normal hemostasis and hematological malignancies.

Main Methods:

  • Literature review of studies on Cbl proteins and platelet function.
  • Analysis of signaling pathways modulated by c-Cbl and Cbl-b in platelets.
  • Examination of the impact of Cbl proteins on platelet activation and aggregation.

Main Results:

  • Cbl proteins act as critical ubiquitin ligases influencing multiple signaling cascades in platelets.
  • These proteins mediate both positive and negative feedback loops in platelet activation.
  • Dysregulation of Cbl proteins is implicated in the pathogenesis of hematological malignancies.

Conclusions:

  • Cbl proteins are indispensable regulators of platelet function.
  • Targeting Cbl-mediated signaling pathways may offer therapeutic strategies for bleeding disorders and thrombosis.
  • Further research into Cbl proteins is vital for understanding platelet biology and related diseases.